# Clinical Study on the Treatment of Elevated Total Bilirubin in Primary Biliary Cholangitis With Baobao Dan Capsule

> **NCT06371196** · PHASE4 · UNKNOWN · sponsor: **Mei Han** · enrollment: 60 (estimated)

## Conditions studied

- Primary Biliary Cholangitis

## Interventions

- **DRUG:** Babaodan Capsule

## Key facts

- **NCT ID:** NCT06371196
- **Lead sponsor:** Mei Han
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-25
- **Primary completion:** 2025-07-25
- **Final completion:** 2025-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06371196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06371196, "Clinical Study on the Treatment of Elevated Total Bilirubin in Primary Biliary Cholangitis With Baobao Dan Capsule". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06371196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*